Healthy Subjects
944
45
56
771
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
80 trials with published results (8%)
Research Maturity
771 completed trials (82% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.1%
20 terminated out of 944 trials
97.5%
+10.9% vs benchmark
2%
23 trials in Phase 3/4
10%
80 of 771 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 771 completed trials
Clinical Trials (944)
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
High Image Matrix CT Reconstruction
Comparison of Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisone
Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)
ABVN Phase 2 - EDS Wearable Device
Pulmonary and Total Blood Volume in COPD
ABVN Phase 2 - PENFS
Bioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects
An Early Feasibility Study of the BioJet™ Oral Biotherapeutic Delivery System for Administration of Therapeutic Agents in Healthy Participants
Lysine-specific Demethylase 1 and Salt-sensitivity in Humans
High Frequency Stimulation to Improve Cognition, Mobility, and Affect in Individuals With and Without Subjective Cognitive Decline
Y-Balance Test Training for Ankle Function and Lower Limb Functional Performance
A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1
In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
The Effects of Urinary pH Changes on an Investigational Compound in Healthy Subjects
Single-tracer Multiparametric PET Imaging
"Effects of Oral Citrulline on Protein Metabolism in Healthy Humans: a Prospective, Randomized, Double-blind , Cross-over Study" (Citrugrêle)
Satiety, Microbiome, Appetite Regulation, and Tracking Energy Across Targeted Snacks: Chronic Study
A Repeat Dose Study of the Dexmedetomidine Transdermal System in Healthy Subjects
Phase 1 Study of Intravaginal KB15A